Global programme to eliminate lymphatic filariasis: progress report, 2014

WHO Weekly Epidemiological Record (WER) – 18 September 2015, Vol. 90, 38

16 pp. 601 kB
http://www.who.int/entity/wer/2015/wer9038.pdf?ua=1Pic 002_resize

Lymphatic filariasis (LF) is targeted for global elimination as a public health problem by 2020. The Global Programme to Eliminate Lymphatic Filariasis (GPELF) was launched in 2000, aiming to stop the spread of infection and alleviate suffering. Mass drug administration (MDA) is the recommended preventive chemotherapy (PC) strategy of delivering safe, anthelminthic drugs to populations at risk of LF to prevent morbidity due to infection and interrupt transmission. When the level of infection has been reduced to below target thresholds, MDA is considered no longer required.

(Visited 32 times, 1 visits today)
This entry was posted in General, Other Infectious Diseases. Bookmark the permalink.